norfloxacin has been researched along with beta-lactams in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guenounou, M; Miguères, ML; Ronco, E | 1 |
| Verbist, L | 1 |
| Liu, S; Meyer, RD | 1 |
| Campbell, ME; Clarke, AM; Zemcov, SJ | 1 |
| Labthavikul, P; Neu, HC | 1 |
| Chin, NX; Neu, HC | 1 |
| Chakrabarti, A; Mukherjee, J; Pal, S; Rahaman, SO | 1 |
| Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
| Amicosante, G; Becerro, P; Casañas, L; Jiménez de Anta, MT; Perilli, M; Tavío, MM; Vila, J | 1 |
| Chumjan, W; Hajjar, E; Mahendran, KR; Schulte, A; Suginta, W; Weingart, H; Winterhalter, M | 1 |
| Cao, Y; Ding, Z; Gong, Y; Jiang, H; Liu, X; Song, X; Wang, F; Wang, T; Wang, W; Zhang, N; Zhang, W; Zhang, Z | 1 |
| Araújo, NJS; Coutinho, HDM; da Silva, ARP; de Freitas, TS; de Sousa, EO; de Vasconcelos, JEL; do Socorro Costa, M; Filho, JMB; Maia, FPA; Pereira Junior, FN; Pinheiro, JCA; Tavares, JF | 1 |
12 other study(ies) available for norfloxacin and beta-lactams
| Article | Year |
|---|---|
[In vitro activity of 4 fluoroquinolones against Klebsiella pneumoniae. Distribution according to phenotype resistance to aminoglycosides or beta-lactams].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; In Vitro Techniques; Klebsiella pneumoniae; Norfloxacin; Ofloxacin; Pefloxacin; Phenotype | 1990 |
In-vitro activity of pefloxacin against micro-organisms multiply resistant to beta-lactam antibiotics and aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Drug Resistance, Microbial; Enterobacteriaceae; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus | 1986 |
In vitro activity of aryl fluoroquinolones, Abbott 56619 and Abbott 56620, compared to ciprofloxacin, norfloxacin and beta-lactams versus multidrug-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Pseudomonas aeruginosa | 1986 |
In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Enoxacin; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin | 1985 |
In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Trimethoprim | 1982 |
In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Colony-Forming Units Assay; Drug Resistance, Microbial; Drug Synergism; Enoxacin; Microbial Sensitivity Tests; Mutagens; Nalidixic Acid; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Trimethoprim | 1983 |
Decreased membrane permeability in a polymyxin B-resistant Escherichia coli mutant exhibiting multiple resistance to beta-lactams as well as aminoglycosides.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Cell Membrane Permeability; Drug Resistance, Microbial; Escherichia coli; Lipopolysaccharides; Mutation; Norfloxacin; Polymyxin B | 1998 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
Salicylate decreases production of AmpC type beta-lactamases and increases susceptibility to beta-lactams in a Morganella morganii clinical isolate.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Humans; Inpatients; Microbial Sensitivity Tests; Morganella morganii; Nalidixic Acid; Norfloxacin; Salicylates; Tetracycline; Urine | 2004 |
Molecular analysis of antimicrobial agent translocation through the membrane porin BpsOmp38 from an ultraresistant Burkholderia pseudomallei strain.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Biological Transport; Burkholderia pseudomallei; Cefepime; Ceftazidime; Cephalosporins; Ertapenem; Humans; Imipenem; Kinetics; Lipid Bilayers; Melioidosis; Meropenem; Models, Molecular; Molecular Sequence Data; Norfloxacin; Penicillin G; Phospholipids; Porins; Protein Conformation; Sequence Homology, Amino Acid; Thienamycins | 2011 |
Efficacy of cefepime, ertapenem and norfloxacin against leptospirosis and for the clearance of pathogens in a hamster model.
Topics: Animal Structures; Animals; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cricetinae; Disease Models, Animal; Ertapenem; Histocytochemistry; Leptospira interrogans serovar autumnalis; Leptospirosis; Norfloxacin; Survival Analysis; Treatment Outcome | 2014 |
Evaluation of the antibacterial and inhibitory activity of NorA and MepA efflux pumps from Staphylococcus aureus by diosgenin.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Diosgenin; Escherichia coli; Ethidium; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Norfloxacin; Saponins; Staphylococcal Infections; Staphylococcus aureus | 2022 |